N/A
N=1,089
Physical and Cognitive Function - Look AHEAD Ancillary Study
Diabetes · Weight Loss · Physical Function · Cognitive Function
Bottom Line
View on ClinicalTrials.gov: NCT01410097 ↗Enrolled (actual)
1,089
Serious AEs
0.0%
Results posted
Nov 2017
Primary outcome: Primary: Short Physical Performance Battery (SPPB) Score — 10.1; 10.0 Score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lifestyle intervention (Behavioral); Diabetes Support Education (Behavioral)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- All
- Sponsor
- Wake Forest University
- Primary completion
- Sep 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Short Physical Performance Battery (SPPB) Score |
10.1; 10.0 | — |
| SECONDARY Gait Speed Over 400 m |
1.07; 1.05 | — |
| SECONDARY Grip Strength |
31; 30.7 | — |
| SECONDARY Knee Extensor Strength |
23.4; 23.4 | — |
| SECONDARY Trail Making Test (Part A & B) |
62.87; 62.85 | — |
| SECONDARY Digit Symbol Substitution Test (DSST) |
41.61; 41.14 | — |
| SECONDARY Rey Auditory Verbal Learning Test (RAVLT) |
7.51; 7.30 | — |
| SECONDARY Modified Stroop Color and Word Test |
39.17; 38.47 | — |
| SECONDARY Modified Mini-Mental Status Exam (3MS) |
92.25; 92.19 | — |
Summary
Obesity is associated with physical disability through both direct pathways (e.g., lower extremity pain, insufficient muscle strength) and indirect pathways (obesity-related comorbidities and inflammation). Furthermore, diabetes, a major obesity-related health condition, is associated with increased risk of disability and accelerated declines in physical and cognitive function. The investigators preliminary data suggest that intentional weight loss improves physical function, and there is strong circumstantial evidence that it would also benefit cognitive function.
To evaluate the role of intentional weight loss on physical and cognitive function, the investigators propose an ancillary study to the on-going Look AHEAD (Action for Health in Diabetes) trial. Look AHEAD is a multi-center, randomized clinical trial to examine the effects of a 4-year lifestyle intervention designed to achieve and maintain weight loss through decreased caloric intake and exercise in overweight or obese men and women aged 45-74 years with type 2 diabetes. The investigators propose to add validated and well-established measures of physical and cognitive performance to the year 8 follow-up visit - during the trial's weight maintenance phase - in ~1000 participants at 4 of the 16 Look AHEAD field sites (Colorado, Memphis, Pennington and Pittsburgh).
The specific aims of this ancillary study are: 1) To determine the long-term effects of a lifestyle intervention designed to achieve and maintain weight loss on physical function; and 2) To determine the long-term effects of a lifestyle intervention designed to achieve and maintain weight loss on cognitive function. In addition, the investigators hypothesize that in the intervention group, larger initial weight loss, better weight loss maintenance, and higher physical activity will be associated with better physical and cognitive function. The investigators also hypothesize that in the control group weight loss will be associated with worse physical and cognitive function than in those who are weight stable or who have gained weight.
The number of obese older adults is rising rapidly and there are few data to guide an evidence-based clinical response to their management. The results of this study will provide the first direct evidence of the role of long-term intentional weight loss on the maintenance of physical and cognitive function in older obese adults with diabetes. Since this study is being done as an ancillary study to an on-going trial it can be done in a timely and cost-efficient manner.
Eligibility Criteria
Inclusion Criteria
- The only inclusion criterion is that the participant is considered "active" at his/her Year 8 or Year 9 visit in the main study.
Exclusion Criteria
- The only exclusion criterion is the person is not willing to participate in this ancillary study.
Data sourced from ClinicalTrials.gov (NCT01410097). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.